Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events

J Tamargo, JC Kaski, T Kimura… - European Heart …, 2022 - academic.oup.com
Awareness of racial/ethnic disparities represents a key challenge for healthcare systems that
attempt to provide effective healthcare and to reduce existing inequalities in the use of and …

Current concepts in coronary artery revascularisation

M Gaudino, F Andreotti, T Kimura - The Lancet, 2023 - thelancet.com
Coronary artery revascularisation can be performed surgically or percutaneously. Surgery is
associated with higher procedural risk and longer recovery than percutaneous interventions …

Paclitaxel-coated balloon vs uncoated balloon for coronary in-stent restenosis: the AGENT IDE randomized clinical trial

RW Yeh, R Shlofmitz, J Moses, W Bachinsky, S Dohad… - Jama, 2024 - jamanetwork.com
Importance Drug-coated balloons offer a potentially beneficial treatment strategy for the
management of coronary in-stent restenosis. However, none have been previously …

JCS 2022 guideline focused update on diagnosis and treatment in patients with stable coronary artery disease

S Nakano, S Kohsaka, T Chikamori, K Fukushima… - Circulation …, 2022 - jstage.jst.go.jp
Coronary artery disease (CAD) remains the leading cause of mortality and morbidity in
developed countries. In patients presenting with acute coronary syndromes (ACS), timely …

[HTML][HTML] Trends and impact of intravascular ultrasound and optical coherence tomography on percutaneous coronary intervention for myocardial infarction

DY Park, E Vemmou, S An, I Nikolakopoulos… - IJC Heart & …, 2023 - Elsevier
Background Intravascular imaging with either intravascular ultrasound (IVUS) or optical
coherence tomography (OCT) during percutaneous coronary intervention (PCI) is …

Artificial intelligence–enabled quantitative coronary plaque and hemodynamic analysis for predicting acute coronary syndrome

BK Koo, S Yang, JW Jung, J Zhang, K Lee… - Cardiovascular …, 2024 - jacc.org
Background A lesion-level risk prediction for acute coronary syndrome (ACS) needs better
characterization. Objectives This study sought to investigate the additive value of artificial …

Bivalirudin versus heparin during PCI in NSTEMI: individual patient data meta-analysis of large randomized trials

B Bikdeli, D Erlinge, M Valgimigli, A Kastrati, Y Han… - Circulation, 2023 - ahajournals.org
BACKGROUND: The benefit: risk profile of bivalirudin versus heparin anticoagulation in
patients with non–ST-segment–elevation myocardial infarction undergoing percutaneous …

Amphilimus-vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial

R Romaguera, P Salinas, J Gomez-Lara… - European Heart …, 2022 - academic.oup.com
Aim Patients with diabetes mellitus are at high risk of adverse events after percutaneous
revascularization, with no differences in outcomes between most contemporary drug-eluting …

2023 AHA/ACC clinical performance and quality measures for coronary artery revascularization: A report of the American college of cardiology/American heart …

Writing Committee Members, GJ Dehmer… - Journal of the American …, 2023 - jacc.org
In 2022, the Joint Committee convened the writing committee to begin develo**
performance and quality measures for coronary artery revascularization. The writing …

Practice patterns and outcomes of transcatheter aortic valve replacement in the United States and Japan: a report from joint data harmonization initiative of STS/ACC …

T Kaneko, S Vemulapalli, S Kohsaka… - Journal of the …, 2022 - ahajournals.org
Background The practice pattern and outcome of medical devices following their regulatory
approval may differ by country. The aim of this study is to compare postapproval national …